Literature DB >> 15846698

Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes.

S L Norris1, X Zhang, A Avenell, E Gregg, T J Brown, C H Schmid, J Lau.   

Abstract

BACKGROUND: Most persons with type 2 diabetes are overweight and obesity worsens the metabolic and physiologic abnormalities associated with diabetes.
OBJECTIVES: The objective of this review is to assess the effectiveness of lifestyle and behavioral weight loss and weight control interventions for adults with type 2 diabetes. SEARCH STRATEGY: Studies were obtained from computerized searches of multiple electronic bibliographic databases, supplemented with hand searches of selected journals and consultation with experts in obesity research. The last search was conducted May, 2004. SELECTION CRITERIA: Studies were included if they were published or unpublished randomized controlled trials in any language, and examined weight loss or weight control strategies using one or more dietary, physical activity, or behavioral interventions, with a follow-up interval of at least 12 months. DATA COLLECTION AND ANALYSIS: Effects were combined using a random effects model. MAIN
RESULTS: The 22 studies of weight loss interventions identified had a 4,659 participants and follow-up of 1 to 5 years. The pooled weight loss for any intervention in comparison to usual care among 585 subjects was 1.7 kg (95 % confidence interval [CI] 0.3 to 3.2), or 3.1% of baseline body weight among 517 subjects. Other main comparisons demonstrated nonsignificant results: among 126 persons receiving a physical activity and behavioral intervention, those who also received a very low calorie diet lost 3.0 kg (95% CI -0.5 to 6.4), or 1.6% of baseline body weight, more than persons receiving a low-calorie diet. Among 53 persons receiving identical dietary and behavioral interventions, those receiving more intense physical activity interventions lost 3.9 kg (95% CI -1.9 to 9.7), or 3.6% of baseline body weight, more than those receiving a less intense or no physical activity intervention. Comparison groups often achieved significant weight loss (up to 10.0 kg), minimizing between-group differences. Changes in glycated hemoglobin generally corresponded to changes in weight and were not significant when between-group differences were examined. No data were identified on quality of life and mortality. AUTHORS'
CONCLUSIONS: Weight loss strategies using dietary, physical activity, or behavioral interventions produced small between-group improvements in weight. These results were minimized by weight loss in the comparison group, however, and examination of individual study arms revealed that multicomponent interventions including very low calorie diets or low calorie diets may hold promise for achieving weight loss in adults with type 2 diabetes.

Entities:  

Mesh:

Year:  2005        PMID: 15846698     DOI: 10.1002/14651858.CD004095.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  44 in total

Review 1.  The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: a review of meta-analyses.

Authors:  Theodora Psaltopoulou; Ioannis Ilias; Maria Alevizaki
Journal:  Rev Diabet Stud       Date:  2010-05-10

Review 2.  Update on the Canadian Diabetes Association 2008 clinical practice guidelines.

Authors:  Onil K Bhattacharyya; Elizabeth A Estey; Alice Y Y Cheng
Journal:  Can Fam Physician       Date:  2009-01       Impact factor: 3.275

3.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

Authors:  Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski; Harmon S Jordan; Karima A Kendall; Linda J Lux; Roycelynn Mentor-Marcel; Laura C Morgan; Michael G Trisolini; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

Review 4.  Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines.

Authors:  Onil K Bhattacharyya; Baiju R Shah; Gillian L Booth
Journal:  CMAJ       Date:  2008-09-18       Impact factor: 8.262

5.  [Pharmacological therapy versus bariatric surgery for patients with obesity and type 2 diabetes].

Authors:  M Blüher
Journal:  Internist (Berl)       Date:  2015-02       Impact factor: 0.743

Review 6.  Therapy for obesity based on gastrointestinal hormones.

Authors:  Jonatan I Bagger; Mikkel Christensen; Filip K Knop; Tina Vilsbøll
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 7.  The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis.

Authors:  Binwu Sheng; Khoa Truong; Hugh Spitler; Lu Zhang; Xuetao Tong; Liwei Chen
Journal:  Obes Surg       Date:  2017-10       Impact factor: 4.129

8.  Methodologies for optimizing behavioral interventions: introduction to special section.

Authors:  William T Riley; Daniel E Rivera
Journal:  Transl Behav Med       Date:  2014-09       Impact factor: 3.046

9.  A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Björknäs study.

Authors:  Margareta K Eriksson; Paul W Franks; Mats Eliasson
Journal:  PLoS One       Date:  2009-04-14       Impact factor: 3.240

10.  Short-term dynamics and metabolic impact of abdominal fat depots after bariatric surgery.

Authors:  Ram Weiss; Liat Appelbaum; Chaya Schweiger; Idit Matot; Naama Constantini; Alon Idan; Noam Shussman; Jacob Sosna; Andrei Keidar
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.